Skip to main content

Articles

Payers' Guide, FDA Approvals

Zioptan Receives FDA Approval for Patients with Open-Angle Glaucoma and/or Ocular Hypertension

Payers' Guide, FDA Approvals

Linzess: A Novel Treatment Option for Constipation Associated with Irritable Bowel Syndrome

Payers' Guide, FDA Approvals

Perjeta: A New Option for Patients with HER2-Positive Metastatic Breast Cancer

FDA Approvals, Payers' Guide

Trends in the 2013 Pharmaceutical Pipeline

Payers' Guide, FDA Approvals

Iclusig: A New Treatment Option for Adults with CML or Ph+ ALL that Is Resistant/ Intolerant to Previous Therapy with TKIs

Payers' Guide, FDA Approvals

Qsymia: Combination Oral Therapy a New Weight-Loss Option for Obese or Overweight Patients

Payers' Guide, FDA Approvals

Rayos: A Novel Oral Delayed-Release Prednisone for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases

Payers' Guide, FDA Approvals

Xeljanz: A New Treatment Option for Patients with Rheumatoid Arthritis

Payers' Guide, FDA Approvals

Tudorza Pressair: A Novel Oral Inhalation Therapy for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease–Associated Bronchospasm

Payers' Guide, FDA Approvals

Vascepa: First EPA-Only Omega-3 Therapy Approved by the FDA for Severe Hypertriglyceridemia

Page 179 of 244
Results 1781 - 1790 of 2436